Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

340 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Biotherapies in metastatic colorectal cancers in 2014].
Jouinot A, Coriat R, Huillard O, Goldwasser F. Jouinot A, et al. Among authors: goldwasser f. Presse Med. 2014 Oct;43(10 Pt 1):1056-66. doi: 10.1016/j.lpm.2014.03.028. Epub 2014 Jul 24. Presse Med. 2014. PMID: 25065664 Review. French.
Clinical pharmacology, drug-drug interactions and safety of pazopanib: a review.
Boudou-Rouquette P, Tlemsani C, Blanchet B, Huillard O, Jouinot A, Arrondeau J, Thomas-Schoemann A, Vidal M, Alexandre J, Goldwasser F. Boudou-Rouquette P, et al. Among authors: goldwasser f. Expert Opin Drug Metab Toxicol. 2016 Dec;12(12):1433-1444. doi: 10.1080/17425255.2016.1225038. Epub 2016 Aug 24. Expert Opin Drug Metab Toxicol. 2016. PMID: 27556889 Review.
Resting energy expenditure in the risk assessment of anticancer treatments.
Jouinot A, Vazeille C, Durand JP, Huillard O, Boudou-Rouquette P, Coriat R, Chapron J, Neveux N, De Bandt JP, Alexandre J, Cynober L, Goldwasser F. Jouinot A, et al. Among authors: goldwasser f. Clin Nutr. 2018 Apr;37(2):558-565. doi: 10.1016/j.clnu.2017.01.007. Epub 2017 Jan 19. Clin Nutr. 2018. PMID: 28143668
Relation between hypermetabolism, cachexia, and survival in cancer patients: a prospective study in 390 cancer patients before initiation of anticancer therapy.
Vazeille C, Jouinot A, Durand JP, Neveux N, Boudou-Rouquette P, Huillard O, Alexandre J, Cynober L, Goldwasser F. Vazeille C, et al. Among authors: goldwasser f. Am J Clin Nutr. 2017 May;105(5):1139-1147. doi: 10.3945/ajcn.116.140434. Epub 2017 Mar 29. Am J Clin Nutr. 2017. PMID: 28356274 Free article.
Sarcopenic overweight is associated with early acute limiting toxicity of anti-PD1 checkpoint inhibitors in melanoma patients.
Heidelberger V, Goldwasser F, Kramkimel N, Jouinot A, Huillard O, Boudou-Rouquette P, Chanal J, Arrondeau J, Franck N, Alexandre J, Blanchet B, Leroy K, Avril MF, Dupin N, Aractingi S. Heidelberger V, et al. Among authors: goldwasser f. Invest New Drugs. 2017 Aug;35(4):436-441. doi: 10.1007/s10637-017-0464-x. Epub 2017 Apr 10. Invest New Drugs. 2017. PMID: 28396974
Clinical parameters associated with anti-programmed death-1 (PD-1) inhibitors-induced tumor response in melanoma patients.
Heidelberger V, Goldwasser F, Kramkimel N, Jouinot A, Franck N, Arrondeau J, Guégan S, Mansuet-Lupo A, Alexandre J, Damotte D, Avril MF, Dupin N, Aractingi S. Heidelberger V, et al. Among authors: goldwasser f. Invest New Drugs. 2017 Dec;35(6):842-847. doi: 10.1007/s10637-017-0476-6. Epub 2017 May 31. Invest New Drugs. 2017. PMID: 28569347
Erratum to: Sarcopenic overweight is associated with early acute limiting toxicity of anti-PD1 checkpoint inhibitors in melanoma patients.
Heidelberger V, Goldwasser F, Kramkimel N, Jouinot A, Huillard O, Boudou-Rouquette P, Chanal J, Arrondeau J, Franck N, Alexandre J, Blanchet B, Leroy K, Avril MF, Dupin N, Aractingi S. Heidelberger V, et al. Among authors: goldwasser f. Invest New Drugs. 2017 Aug;35(4):537. doi: 10.1007/s10637-017-0475-7. Invest New Drugs. 2017. PMID: 28597150 No abstract available.
Reply to N Dominguez and T Canada.
Vazeille C, Jouinot A, Durand JP, Cynober L, Goldwasser F. Vazeille C, et al. Among authors: goldwasser f. Am J Clin Nutr. 2017 Sep;106(3):958-959. doi: 10.3945/ajcn.117.162107. Am J Clin Nutr. 2017. PMID: 28864589 Free article. No abstract available.
Resting energy metabolism and anticancer treatments.
Jouinot A, Vazeille C, Goldwasser F. Jouinot A, et al. Among authors: goldwasser f. Curr Opin Clin Nutr Metab Care. 2018 May;21(3):145-151. doi: 10.1097/MCO.0000000000000457. Curr Opin Clin Nutr Metab Care. 2018. PMID: 29369114 Review.
340 results